Forian Inc., a provider of data science driven information and analytics solutions to life science, healthcare and financial services industries, reported financial results for the fourth quarter and full year ended December 31, 2025. The company demonstrated substantial revenue growth while managing costs and making strategic investments in its platform.
For the full year 2025, revenue reached $30.3 million, representing a 50% increase from $20.2 million in 2024. This growth was driven by key contract renewals that offset industry churn and data supply challenges. The company achieved its revenue guidance target and delivered on its adjusted EBITDA margin profile while continuing to invest across the business. Adjusted EBITDA for the year was $0.8 million, a 72% improvement from $0.5 million in the prior year.
Fourth quarter results showed continued momentum with revenue of $8.0 million, a 37% increase from $5.8 million in the same period last year. However, the company reported a net loss of $(1.8) million for the quarter, compared to net income of $0.2 million in the prior year period. This shift reflects increased strategic investments and transaction-related expenses. The company maintained a strong balance sheet with $31.6 million in cash, cash equivalents and marketable securities at year-end.
Chief Executive Officer Max Wygod stated that 2025 demonstrated how disciplined cost management and strategic investment can work together. The company grew its business, expanded into new markets, and made targeted investments in its data platform and product development while preserving balance sheet strength. Key achievements included strengthening the data platform through expanded contracting activity and onboarding new clinical data feeds, which addressed upstream data supply challenges. The company also extended its market penetration with life sciences customers, as pharmaceutical and biotech companies increasingly adopted Forian's data and analytics offerings.
A significant corporate development emerged on August 25, 2025, when a consortium led by Forian's Chief Executive Officer and Executive Chair submitted a non-binding proposal to acquire all outstanding shares not currently owned by the consortium. A Special Committee formed to evaluate this proposal remains in place and is in discussions with the consortium. The company noted there can be no assurance that any transaction will result from these discussions, that terms would be acceptable, or regarding timing of any potential transaction. Forian stated it does not intend to comment further unless a definitive agreement is reached or disclosure becomes appropriate or required.
The financial results highlight Forian's position in the competitive data analytics sector, where companies providing actionable insights from healthcare and life sciences data are increasingly valuable. The company's ability to grow revenue substantially while navigating data supply challenges demonstrates resilience in a complex market. The potential acquisition talks add another layer of significance, as management-led buyouts can signal confidence in long-term prospects while potentially altering the company's strategic direction.
Forian provides information through its website at https://www.forian.com, where investors can access additional details about the company's operations and financial performance. The original press release was published on https://www.newmediawire.com, providing the complete financial disclosure and reconciliation of GAAP to non-GAAP measures.
The company's performance reflects broader trends in healthcare data analytics, where organizations are increasingly relying on sophisticated data science to optimize operational, clinical and financial performance. Forian's expansion in pharmaceutical and biotech markets indicates growing demand for specialized analytics in drug development and commercialization. The financial results and corporate developments will be closely watched by investors assessing the company's trajectory amid ongoing industry transformation and potential ownership changes.
